Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Wim M. Mulleners, Byung‐Kun Kim, Miguel J. A. Láinez, Michel Lantéri‐Minet, Patricia Pozo‐Rosich, Shufang Wang, Antje Tockhorn‐Heidenreich, Sheena K. Aurora, Russell Nichols, Laura Yunes‐Medina, Holland C. Detke